376 related articles for article (PubMed ID: 33188876)
61. The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.
Kilmister EJ; Tan ST
J Histochem Cytochem; 2021 Dec; 69(12):835-847. PubMed ID: 34165363
[TBL] [Abstract][Full Text] [Related]
62. Cancer stem cells and their vascular niche: Do they benefit from each other?
Ping YF; Zhang X; Bian XW
Cancer Lett; 2016 Oct; 380(2):561-567. PubMed ID: 25979233
[TBL] [Abstract][Full Text] [Related]
63. Intra-tumor heterogeneity from a cancer stem cell perspective.
Prasetyanti PR; Medema JP
Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
[TBL] [Abstract][Full Text] [Related]
64. Reactive oxygen species in cancer stem cells of head and neck squamous cancer.
Qian X; Nie X; Yao W; Klinghammer K; Sudhoff H; Kaufmann AM; Albers AE
Semin Cancer Biol; 2018 Dec; 53():248-257. PubMed ID: 29935313
[TBL] [Abstract][Full Text] [Related]
65. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting.
Heng WS; Gosens R; Kruyt FAE
Biochem Pharmacol; 2019 Feb; 160():121-133. PubMed ID: 30557553
[TBL] [Abstract][Full Text] [Related]
66. Tackling the cancer stem cells - what challenges do they pose?
Pattabiraman DR; Weinberg RA
Nat Rev Drug Discov; 2014 Jul; 13(7):497-512. PubMed ID: 24981363
[TBL] [Abstract][Full Text] [Related]
67. Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma.
Chiou GY; Cherng JY; Hsu HS; Wang ML; Tsai CM; Lu KH; Chien Y; Hung SC; Chen YW; Wong CI; Tseng LM; Huang PI; Yu CC; Hsu WH; Chiou SH
J Control Release; 2012 Apr; 159(2):240-50. PubMed ID: 22285547
[TBL] [Abstract][Full Text] [Related]
68. Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
Deng S; Wong CKC; Lai HC; Wong AST
Oncotarget; 2017 Apr; 8(16):25897-25914. PubMed ID: 27825116
[TBL] [Abstract][Full Text] [Related]
69. The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors.
Fonseca NA; Cruz AF; Moura V; Simões S; Moreira JN
Crit Rev Oncol Hematol; 2017 May; 113():111-121. PubMed ID: 28427501
[TBL] [Abstract][Full Text] [Related]
70. Epigenetic Regulation of Inflammatory Cytokine-Induced Epithelial-To-Mesenchymal Cell Transition and Cancer Stem Cell Generation.
Markopoulos GS; Roupakia E; Marcu KB; Kolettas E
Cells; 2019 Sep; 8(10):. PubMed ID: 31557902
[TBL] [Abstract][Full Text] [Related]
71. Therapeutic targeting of CBP/β-catenin signaling reduces cancer stem-like population and synergistically suppresses growth of EBV-positive nasopharyngeal carcinoma cells with cisplatin.
Chan KC; Chan LS; Ip JC; Lo C; Yip TT; Ngan RK; Wong RN; Lo KW; Ng WT; Lee AW; Tsao GS; Kahn M; Lung ML; Mak NK
Sci Rep; 2015 Apr; 5():9979. PubMed ID: 25897700
[TBL] [Abstract][Full Text] [Related]
72. Bile acid: a potential inducer of colon cancer stem cells.
Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
[TBL] [Abstract][Full Text] [Related]
73. A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness.
Chimal-Ramírez GK; Espinoza-Sánchez NA; Fuentes-Pananá EM
Anticancer Agents Med Chem; 2015; 15(7):837-55. PubMed ID: 25783962
[TBL] [Abstract][Full Text] [Related]
74. Noncanonical roles of p53 in cancer stemness and their implications in sarcomas.
Curylova L; Ramos H; Saraiva L; Skoda J
Cancer Lett; 2022 Jan; 525():131-145. PubMed ID: 34742870
[TBL] [Abstract][Full Text] [Related]
75. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
Kim JK; Jeon HY; Kim H
Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
[TBL] [Abstract][Full Text] [Related]
76. Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells.
Luo S; Yang G; Ye P; Cao N; Chi X; Yang WH; Yan X
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740975
[TBL] [Abstract][Full Text] [Related]
77. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
[TBL] [Abstract][Full Text] [Related]
78. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
79. Colorectal cancer defeating? Challenge accepted!
Di Franco S; Todaro M; Dieli F; Stassi G
Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
[TBL] [Abstract][Full Text] [Related]
80. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition.
Katsuno Y; Meyer DS; Zhang Z; Shokat KM; Akhurst RJ; Miyazono K; Derynck R
Sci Signal; 2019 Feb; 12(570):. PubMed ID: 30808819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
